COVID-19: BCG As Therapeutic Vaccine, Transmission Limitation, and Immunoglobulin Enhancement
Clinical trial NCT04369794 · COMPLETED
Trial details
- NCT number
- NCT04369794
- Sponsor
- University of Campinas, Brazil
- Status
- COMPLETED
- Phase
- Phase 4
- Study type
- INTERVENTIONAL
- Start date
- 2020-10-01
- Primary completion
- 2022-06-04
- Enrollment
- 400
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.